Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veracyte, Inc. - Common Stock (NQ:VCYT)

31.14 -0.09 (-0.29%)
Streaming Delayed Price Updated: 3:40 PM EDT, Mar 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Veracyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth
From Veracyte, Inc.
Via Business Wire
Veracyte to Release Second Quarter 2021 Financial Results on July 29, 2021
From Veracyte, Inc.
Via Business Wire
Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion
From Veracyte, Inc.
Via Business Wire
Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical Team
From Veracyte, Inc.
Via Business Wire
New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder
From Veracyte, Inc.
Via Business Wire
CORRECTING and REPLACING Veracyte to Present at Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
Veracyte to Present at Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
From Veracyte, Inc.
Via Business Wire
Veracyte to Present at Upcoming Investor Conferences
From Veracyte
Via Business Wire
Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples
From Veracyte, Inc.
Via Business Wire
Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier
From Veracyte, Inc.
Via Business Wire
Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
From Veracyte, Inc.
Via Business Wire
Veracyte to Present at Upcoming Investor Conferences
From Veracyte, Inc.
Via Business Wire
Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis
From Veracyte
Via Business Wire
Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
From Veracyte, Inc.
Via Business Wire
Veracyte, Inc. Announces CEO Succession Plan
From Veracyte, Inc.
Via Business Wire
Veracyte Announces First Quarter 2021 Financial Results
From Veracyte, Inc.
Via Business Wire
Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress
From Veracyte, Inc.
Via Business Wire
Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO
From Veracyte, Inc.
Via Business Wire
Veracyte Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis
From Veracyte, Inc.
Via Business Wire
Veracyte to Release First Quarter 2021 Financial Results on May 10, 2021
From Veracyte, Inc.
Via Business Wire
Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference
From Veracyte
Via Business Wire
Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results
From Veracyte, Inc.
Via Business Wire
Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test
From Veracyte
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.